<abstracts-retrieval-response xmlns="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:dn="http://www.elsevier.com/xml/svapi/abstract/dtd" xmlns:ait="http://www.elsevier.com/xml/ani/ait" xmlns:ce="http://www.elsevier.com/xml/ani/common" xmlns:cto="http://www.elsevier.com/xml/cto/dtd" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/" xmlns:xocs="http://www.elsevier.com/xml/xocs/dtd" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><coredata><prism:url>https://api.elsevier.com/content/abstract/scopus_id/85068319329</prism:url><dc:identifier>SCOPUS_ID:85068319329</dc:identifier><eid>2-s2.0-85068319329</eid><prism:doi>10.1007/978-3-030-21642-9_32</prism:doi><dc:title>Connection between the parkinson’s disease subtypes and patients’ symptoms progression</dc:title><prism:aggregationType>Book Series</prism:aggregationType><srctype>k</srctype><subtype>cp</subtype><subtypeDescription>Conference Paper</subtypeDescription><citedby-count>0</citedby-count><prism:publicationName>Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)</prism:publicationName><dc:publisher>Springer Verlagservice@springer.de</dc:publisher><source-id>25674</source-id><prism:isbn>9783030216412</prism:isbn><prism:issn>16113349 03029743</prism:issn><prism:volume>11526 LNAI</prism:volume><prism:startingPage>263</prism:startingPage><prism:endingPage>268</prism:endingPage><prism:pageRange>263-268</prism:pageRange><prism:coverDate>2019-01-01</prism:coverDate><openaccess>0</openaccess><openaccessFlag>false</openaccessFlag><dc:creator><author seq="1" auid="56938904000"><ce:initials>A.</ce:initials><ce:indexed-name>Valmarska A.</ce:indexed-name><ce:surname>Valmarska</ce:surname><ce:given-name>Anita</ce:given-name><preferred-name><ce:initials>A.</ce:initials><ce:indexed-name>Valmarska A.</ce:indexed-name><ce:surname>Valmarska</ce:surname><ce:given-name>Anita</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/56938904000</author-url><affiliation id="60023955" href="https://api.elsevier.com/content/affiliation/affiliation_id/60023955"/></author></dc:creator><dc:description><abstract xmlns="" original="y" xml:lang="eng"><publishercopyright>© Springer Nature Switzerland AG 2019.</publishercopyright><ce:para>Parkinson’s disease (PD) is a neurodegenerative disease characterized by a variety of symptoms. Clinicians studying movement disorders have tried to connect the variability of symptoms to underlying subtypes of PD, the two most common being tremor dominant (TD) and postural instability and gait difficulty dominant (PIGD). This paper investigates the connection between the Parkinson’s disease PIGD and TD subtypes, and patients’ symptoms progression. We present a set of symptoms closely related to each subtype as well as the patients’ statuses that indicate a switch in subtype classification. Detection of patients’ symptoms that possibly lead towards subtype change can contribute to the more personalized treatment of PD patients. The results of experiments on Parkinson’s Progression Markers Initiative (PPMI) data suggest the connection of the PIGD subtype to non-motor symptoms associated with decreased quality of life.</ce:para></abstract></dc:description><link href="https://api.elsevier.com/content/abstract/scopus_id/85068319329" rel="self"/><link href="https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&amp;scp=85068319329&amp;origin=inward" rel="scopus"/><link href="https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&amp;scp=85068319329&amp;origin=inward" rel="scopus-citedby"/></coredata><affiliation id="60031106" href="https://api.elsevier.com/content/affiliation/affiliation_id/60031106"><affilname>University of Ljubljana</affilname><affiliation-city>Ljubljana</affiliation-city><affiliation-country>Slovenia</affiliation-country></affiliation><affiliation id="60025254" href="https://api.elsevier.com/content/affiliation/affiliation_id/60025254"><affilname>University of Nova Gorica</affilname><affiliation-city>Nova Gorica</affiliation-city><affiliation-country>Slovenia</affiliation-country></affiliation><affiliation id="60023955" href="https://api.elsevier.com/content/affiliation/affiliation_id/60023955"><affilname>Jozef Stefan Institute</affilname><affiliation-city>Ljubljana</affiliation-city><affiliation-country>Slovenia</affiliation-country></affiliation><authors><author seq="1" auid="56938904000"><ce:initials>A.</ce:initials><ce:indexed-name>Valmarska A.</ce:indexed-name><ce:surname>Valmarska</ce:surname><ce:given-name>Anita</ce:given-name><preferred-name><ce:initials>A.</ce:initials><ce:indexed-name>Valmarska A.</ce:indexed-name><ce:surname>Valmarska</ce:surname><ce:given-name>Anita</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/56938904000</author-url><affiliation id="60023955" href="https://api.elsevier.com/content/affiliation/affiliation_id/60023955"/></author><author seq="2" auid="55319307300"><ce:initials>D.</ce:initials><ce:indexed-name>Miljkovic D.</ce:indexed-name><ce:surname>Miljkovic</ce:surname><ce:given-name>Dragana</ce:given-name><preferred-name><ce:initials>D.</ce:initials><ce:indexed-name>Miljkovic D.</ce:indexed-name><ce:surname>Miljkovic</ce:surname><ce:given-name>Dragana</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/55319307300</author-url><affiliation id="60023955" href="https://api.elsevier.com/content/affiliation/affiliation_id/60023955"/></author><author seq="3" auid="57209641521"><ce:initials>M.</ce:initials><ce:indexed-name>Robnik-Sikonja M.</ce:indexed-name><ce:surname>Robnik–Šikonja</ce:surname><ce:given-name>Marko</ce:given-name><preferred-name><ce:initials>M.</ce:initials><ce:indexed-name>Robnik–Šikonja M.</ce:indexed-name><ce:surname>Robnik–Šikonja</ce:surname><ce:given-name>Marko</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/57209641521</author-url><affiliation id="60031106" href="https://api.elsevier.com/content/affiliation/affiliation_id/60031106"/></author><author seq="4" auid="7004388979"><ce:initials>N.</ce:initials><ce:indexed-name>Lavrac N.</ce:indexed-name><ce:surname>Lavrač</ce:surname><ce:given-name>Nada</ce:given-name><preferred-name><ce:initials>N.</ce:initials><ce:indexed-name>Lavrač N.</ce:indexed-name><ce:surname>Lavrač</ce:surname><ce:given-name>Nada</ce:given-name></preferred-name><author-url>https://api.elsevier.com/content/author/author_id/7004388979</author-url><affiliation id="60023955" href="https://api.elsevier.com/content/affiliation/affiliation_id/60023955"/><affiliation id="60025254" href="https://api.elsevier.com/content/affiliation/affiliation_id/60025254"/></author></authors><language xml:lang="eng"/><authkeywords/><idxterms><mainterm weight="b" candidate="n">Movement disorders</mainterm><mainterm weight="b" candidate="n">Postural instabilities</mainterm><mainterm weight="b" candidate="n">Quality of life</mainterm></idxterms><subject-areas><subject-area code="2614" abbrev="MATH">Theoretical Computer Science</subject-area><subject-area code="1700" abbrev="COMP">Computer Science (all)</subject-area></subject-areas><item xmlns=""><xocs:meta><xocs:funding-list has-funding-info="1" pui-match="primary"><xocs:funding-addon-generated-timestamp>2019-07-13T10:29:13Z</xocs:funding-addon-generated-timestamp><xocs:funding-addon-type>http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/nlp</xocs:funding-addon-type><xocs:funding><xocs:funding-agency-matched-string>Slovenian Research Agency research core</xocs:funding-agency-matched-string><xocs:funding-id>P2-0103</xocs:funding-id></xocs:funding><xocs:funding-text>Acknowledgments. We acknowledge the support of the Slovenian Research Agency research core funding program P2-0103. The data used were obtained from the Parkinson’s Progression Markers Initiative (PPMI) (www.ppmi-info.org/data).</xocs:funding-text></xocs:funding-list></xocs:meta><ait:process-info><ait:date-delivered day="09" month="07" timestamp="2019-07-09T14:48:35.000035-04:00" year="2019"/><ait:date-sort day="01" month="01" year="2019"/><ait:status stage="S300" state="new" type="core"/></ait:process-info><bibrecord><item-info><copyright type="Elsevier">Copyright 2019 Elsevier B.V., All rights reserved.</copyright><itemidlist><ce:doi>10.1007/978-3-030-21642-9_32</ce:doi><itemid idtype="PUI">628384686</itemid><itemid idtype="CAR-ID">918425836</itemid><itemid idtype="CPX">20192707151977</itemid><itemid idtype="SCOPUS">20191906907</itemid><itemid idtype="SCP">85068319329</itemid><itemid idtype="SGR">85068319329</itemid></itemidlist><history><date-created day="08" month="07" timestamp="BST 06:02:12" year="2019"/></history><dbcollection>CPX</dbcollection><dbcollection>SCOPUS</dbcollection><dbcollection>Scopusbase</dbcollection></item-info><head><citation-info><citation-type code="cp"/><citation-language xml:lang="eng" language="English"/><abstract-language xml:lang="eng" language="English"/></citation-info><citation-title><titletext original="y" xml:lang="eng" language="English">Connection between the parkinson’s disease subtypes and patients’ symptoms progression</titletext></citation-title><author-group><author auid="56938904000" seq="1" type="auth"><ce:initials>A.</ce:initials><ce:indexed-name>Valmarska A.</ce:indexed-name><ce:surname>Valmarska</ce:surname><ce:given-name>Anita</ce:given-name><preferred-name><ce:initials>A.</ce:initials><ce:indexed-name>Valmarska A.</ce:indexed-name><ce:surname>Valmarska</ce:surname><ce:given-name>Anita</ce:given-name></preferred-name></author><author auid="55319307300" seq="2" type="auth"><ce:initials>D.</ce:initials><ce:indexed-name>Miljkovic D.</ce:indexed-name><ce:surname>Miljkovic</ce:surname><ce:given-name>Dragana</ce:given-name><preferred-name><ce:initials>D.</ce:initials><ce:indexed-name>Miljkovic D.</ce:indexed-name><ce:surname>Miljkovic</ce:surname><ce:given-name>Dragana</ce:given-name></preferred-name></author><author auid="7004388979" seq="4" type="auth"><ce:initials>N.</ce:initials><ce:indexed-name>Lavrac N.</ce:indexed-name><ce:surname>Lavrač</ce:surname><ce:given-name>Nada</ce:given-name><preferred-name><ce:initials>N.</ce:initials><ce:indexed-name>Lavrač N.</ce:indexed-name><ce:surname>Lavrač</ce:surname><ce:given-name>Nada</ce:given-name></preferred-name></author><affiliation afid="60023955" country="svn"><organization>Jožef Stefan Institute</organization><address-part>Jamova 39</address-part><city>Ljubljana</city><ce:source-text>Jožef Stefan Institute, Jamova 39, Ljubljana, Slovenia</ce:source-text><affiliation-id afid="60023955"/><country>Slovenia</country></affiliation></author-group><author-group><author auid="57209641521" seq="3" type="auth"><ce:initials>M.</ce:initials><ce:indexed-name>Robnik-Sikonja M.</ce:indexed-name><ce:surname>Robnik–Šikonja</ce:surname><ce:given-name>Marko</ce:given-name><preferred-name><ce:initials>M.</ce:initials><ce:indexed-name>Robnik–Šikonja M.</ce:indexed-name><ce:surname>Robnik–Šikonja</ce:surname><ce:given-name>Marko</ce:given-name></preferred-name></author><affiliation afid="60031106" country="svn"><organization>Faculty of Computer and Information Science</organization><organization>University of Ljubljana</organization><city>Ljubljana</city><ce:source-text>Faculty of Computer and Information Science, University of Ljubljana, Ljubljana, Slovenia</ce:source-text><affiliation-id afid="60031106"/><country>Slovenia</country></affiliation></author-group><author-group><author auid="7004388979" seq="4" type="auth"><ce:initials>N.</ce:initials><ce:indexed-name>Lavrac N.</ce:indexed-name><ce:surname>Lavrač</ce:surname><ce:given-name>Nada</ce:given-name><preferred-name><ce:initials>N.</ce:initials><ce:indexed-name>Lavrač N.</ce:indexed-name><ce:surname>Lavrač</ce:surname><ce:given-name>Nada</ce:given-name></preferred-name></author><affiliation afid="60025254" country="svn"><organization>University of Nova Gorica</organization><address-part>Vipavska 13</address-part><city>Nova Gorica</city><ce:source-text>University of Nova Gorica, Vipavska 13, Nova Gorica, Slovenia</ce:source-text><affiliation-id afid="60025254"/><country>Slovenia</country></affiliation></author-group><correspondence><person><ce:initials>A.</ce:initials><ce:indexed-name>Valmarska A.</ce:indexed-name><ce:surname>Valmarska</ce:surname><ce:given-name>Anita</ce:given-name></person><affiliation country="svn"><organization>Jožef Stefan Institute</organization><address-part>Jamova 39</address-part><city>Ljubljana</city><ce:source-text>Jožef Stefan Institute, Jamova 39, Ljubljana, Slovenia</ce:source-text><country>Slovenia</country></affiliation></correspondence><grantlist complete="y"><grant><grant-id>P2-0103</grant-id><grant-acronym>ARRS</grant-acronym><grant-agency iso-code="svn">Javna Agencija za Raziskovalno Dejavnost RS</grant-agency><grant-agency-id>501100004329</grant-agency-id></grant><grant-text xml:lang="eng">We acknowledge the support of the Slovenian Research Agency research core funding program P2-0103. The data used were obtained from the Parkinson’s Progression Markers Initiative (PPMI) (www.ppmi-info.org/data).</grant-text></grantlist><abstracts><abstract original="y" xml:lang="eng"><publishercopyright>© Springer Nature Switzerland AG 2019.</publishercopyright><ce:para>Parkinson’s disease (PD) is a neurodegenerative disease characterized by a variety of symptoms. Clinicians studying movement disorders have tried to connect the variability of symptoms to underlying subtypes of PD, the two most common being tremor dominant (TD) and postural instability and gait difficulty dominant (PIGD). This paper investigates the connection between the Parkinson’s disease PIGD and TD subtypes, and patients’ symptoms progression. We present a set of symptoms closely related to each subtype as well as the patients’ statuses that indicate a switch in subtype classification. Detection of patients’ symptoms that possibly lead towards subtype change can contribute to the more personalized treatment of PD patients. The results of experiments on Parkinson’s Progression Markers Initiative (PPMI) data suggest the connection of the PIGD subtype to non-motor symptoms associated with decreased quality of life.</ce:para></abstract></abstracts><source country="deu" srcid="25674" type="k"><sourcetitle>Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)</sourcetitle><sourcetitle-abbrev>Lect. Notes Comput. Sci.</sourcetitle-abbrev><translated-sourcetitle xml:lang="eng">Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics)</translated-sourcetitle><issuetitle>Artificial Intelligence in Medicine - 17th Conference on Artificial Intelligence in Medicine, AIME 2019, Proceedings</issuetitle><issn type="electronic">16113349</issn><issn type="print">03029743</issn><isbn length="13" level="volume" type="print">9783030216412</isbn><volisspag><voliss volume="11526 LNAI"/><pagerange first="263" last="268"/></volisspag><publicationyear first="2019"/><publicationdate><year>2019</year><date-text xfab-added="true">2019</date-text></publicationdate><website><ce:e-address type="email">https://www.springer.com/series/558</ce:e-address></website><contributor-group><contributor role="edit" seq="1"><ce:initials>S.</ce:initials><ce:indexed-name>Wilk S.</ce:indexed-name><ce:surname>Wilk</ce:surname><ce:given-name>Szymon</ce:given-name></contributor></contributor-group><contributor-group><contributor role="edit" seq="1"><ce:initials>A.</ce:initials><ce:indexed-name>ten Teije A.</ce:indexed-name><ce:surname>ten Teije</ce:surname><ce:given-name>Annette</ce:given-name></contributor></contributor-group><contributor-group><contributor role="edit" seq="1"><ce:initials>D.</ce:initials><ce:indexed-name>Riano D.</ce:indexed-name><ce:surname>Riaño</ce:surname><ce:given-name>David</ce:given-name></contributor></contributor-group><publisher><publishername>Springer Verlag</publishername><ce:e-address type="email">service@springer.de</ce:e-address></publisher><additional-srcinfo><conferenceinfo><confevent><confname>17th Conference on Artificial Intelligence in Medicine, AIME 2019</confname><confnumber>17th</confnumber><confseriestitle>Conference on Artificial Intelligence in Medicine</confseriestitle><conflocation country="pol"><city>Poznan</city></conflocation><confdate><startdate day="26" month="06" year="2019"/><enddate day="29" month="06" year="2019"/></confdate><confcode>227519</confcode></confevent><confpublication><procpartno>1 of 1</procpartno></confpublication></conferenceinfo></additional-srcinfo></source><enhancement><classificationgroup><classifications type="CPXCLASS"><classification> <classification-code>461.6</classification-code> <classification-description>Medicine</classification-description> </classification><classification> <classification-code>723.4</classification-code> <classification-description>Artificial Intelligence</classification-description> </classification><classification> <classification-code>801</classification-code> <classification-description>Chemistry</classification-description> </classification></classifications><classifications type="FLXCLASS"><classification> <classification-code>902</classification-code> <classification-description>FLUIDEX; Related Topics</classification-description> </classification></classifications><classifications type="ASJC"><classification>2614</classification><classification>1700</classification></classifications><classifications type="SUBJABBR"><classification>MATH</classification><classification>COMP</classification></classifications></classificationgroup></enhancement></head><tail><bibliography refcount="6"><reference id="1"><ref-info><ref-title><ref-titletext>Clinical criteria for subtyping Parkinson’s disease: Biomarkers and longitudinal progression</ref-titletext></ref-title><refd-itemidlist><itemid idtype="SGR">85022320174</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>S.M.</ce:initials><ce:indexed-name>Fereshtehnejad S.M.</ce:indexed-name><ce:surname>Fereshtehnejad</ce:surname></author><author seq="2"><ce:initials>R.B.</ce:initials><ce:indexed-name>Postuma R.B.</ce:indexed-name><ce:surname>Postuma</ce:surname></author><author seq="3"><ce:initials>A.</ce:initials><ce:indexed-name>Dagher A.</ce:indexed-name><ce:surname>Dagher</ce:surname></author><author seq="4"><ce:initials>Y.</ce:initials><ce:indexed-name>Zeighami Y.</ce:indexed-name><ce:surname>Zeighami</ce:surname></author></ref-authors><ref-sourcetitle>Brain</ref-sourcetitle><ref-publicationyear first="2017"/><ref-volisspag><voliss issue="7" volume="140"/><pagerange first="1959" last="1976"/></ref-volisspag></ref-info><ref-fulltext>Fereshtehnejad, S.M., Postuma, R.B., Dagher, A., Zeighami, Y.: Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression. Brain 140(7), 1959–1976 (2017)</ref-fulltext><ce:source-text>Fereshtehnejad, S.M., Postuma, R.B., Dagher, A., Zeighami, Y.: Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression. Brain 140(7), 1959–1976 (2017)</ce:source-text></reference><reference id="2"><ref-info><ref-title><ref-titletext>Variable expression of Parkinson’s disease-a base-line analysis of the DATATOP cohort</ref-titletext></ref-title><refd-itemidlist><itemid idtype="SGR">0025086894</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>J.</ce:initials><ce:indexed-name>Jankovic J.</ce:indexed-name><ce:surname>Jankovic</ce:surname></author><et-al/></ref-authors><ref-sourcetitle>Neurology</ref-sourcetitle><ref-publicationyear first="1990"/><ref-volisspag><voliss issue="10" volume="40"/><pagerange first="1529" last="1529"/></ref-volisspag></ref-info><ref-fulltext>Jankovic, J., et al.: Variable expression of Parkinson’s disease-a base-line analysis of the DATATOP cohort. Neurology 40(10), 1529–1529 (1990)</ref-fulltext><ce:source-text>Jankovic, J., et al.: Variable expression of Parkinson’s disease-a base-line analysis of the DATATOP cohort. Neurology 40(10), 1529–1529 (1990)</ce:source-text></reference><reference id="3"><ref-info><ref-title><ref-titletext>The Parkinson’s Progression Markers Initiative (PPMI)</ref-titletext></ref-title><refd-itemidlist><itemid idtype="SGR">82755161902</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>K.</ce:initials><ce:indexed-name>Marek K.</ce:indexed-name><ce:surname>Marek</ce:surname></author><et-al/></ref-authors><ref-sourcetitle>Prog. Neurobiol.</ref-sourcetitle><ref-publicationyear first="2011"/><ref-volisspag><voliss issue="4" volume="95"/><pagerange first="629" last="635"/></ref-volisspag></ref-info><ref-fulltext>Marek, K., et al.: The Parkinson’s Progression Markers Initiative (PPMI). Prog. Neurobiol. 95(4), 629–635 (2011)</ref-fulltext><ce:source-text>Marek, K., et al.: The Parkinson’s Progression Markers Initiative (PPMI). Prog. Neurobiol. 95(4), 629–635 (2011)</ce:source-text></reference><reference id="4"><ref-info><ref-title><ref-titletext>Explaining classifications for individual instances</ref-titletext></ref-title><refd-itemidlist><itemid idtype="SGR">52949101606</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>M.</ce:initials><ce:indexed-name>Robnik-Ikonja M.</ce:indexed-name><ce:surname>Robnik-Ikonja</ce:surname></author><author seq="2"><ce:initials>I.</ce:initials><ce:indexed-name>Kononenko I.</ce:indexed-name><ce:surname>Kononenko</ce:surname></author></ref-authors><ref-sourcetitle>IEEE Trans. Knowl. Data Eng.</ref-sourcetitle><ref-publicationyear first="2008"/><ref-volisspag><voliss issue="5" volume="20"/><pagerange first="589" last="600"/></ref-volisspag></ref-info><ref-fulltext>Robnik-Ikonja, M., Kononenko, I.: Explaining classifications for individual instances. IEEE Trans. Knowl. Data Eng. 20(5), 589–600 (2008)</ref-fulltext><ce:source-text>Robnik-Ikonja, M., Kononenko, I.: Explaining classifications for individual instances. IEEE Trans. Knowl. Data Eng. 20(5), 589–600 (2008)</ce:source-text></reference><reference id="5"><ref-info><ref-title><ref-titletext>How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson’s disease rating scale: Comparison with the unified Parkinson’s disease rating scale</ref-titletext></ref-title><refd-itemidlist><itemid idtype="SGR">84877927516</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>G.T.</ce:initials><ce:indexed-name>Stebbins G.T.</ce:indexed-name><ce:surname>Stebbins</ce:surname></author><author seq="2"><ce:initials>C.G.</ce:initials><ce:indexed-name>Goetz C.G.</ce:indexed-name><ce:surname>Goetz</ce:surname></author><author seq="3"><ce:initials>D.J.</ce:initials><ce:indexed-name>Burn D.J.</ce:indexed-name><ce:surname>Burn</ce:surname></author><author seq="4"><ce:initials>J.</ce:initials><ce:indexed-name>Jankovic J.</ce:indexed-name><ce:surname>Jankovic</ce:surname></author><author seq="5"><ce:initials>T.K.</ce:initials><ce:indexed-name>Khoo T.K.</ce:indexed-name><ce:surname>Khoo</ce:surname></author><author seq="6"><ce:initials>B.C.</ce:initials><ce:indexed-name>Tilley B.C.</ce:indexed-name><ce:surname>Tilley</ce:surname></author></ref-authors><ref-sourcetitle>Mov. Disord.</ref-sourcetitle><ref-publicationyear first="2013"/><ref-volisspag><voliss issue="5" volume="28"/><pagerange first="668" last="670"/></ref-volisspag></ref-info><ref-fulltext>Stebbins, G.T., Goetz, C.G., Burn, D.J., Jankovic, J., Khoo, T.K., Tilley, B.C.: How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson’s disease rating scale: comparison with the unified Parkinson’s disease rating scale. Mov. Disord. 28(5), 668–670 (2013)</ref-fulltext><ce:source-text>Stebbins, G.T., Goetz, C.G., Burn, D.J., Jankovic, J., Khoo, T.K., Tilley, B.C.: How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson’s disease rating scale: comparison with the unified Parkinson’s disease rating scale. Mov. Disord. 28(5), 668–670 (2013)</ce:source-text></reference><reference id="6"><ref-info><ref-title><ref-titletext>Symptoms and medications change patterns for Parkinson’s disease patients stratification</ref-titletext></ref-title><refd-itemidlist><itemid idtype="SGR">85047253343</itemid></refd-itemidlist><ref-authors><author seq="1"><ce:initials>A.</ce:initials><ce:indexed-name>Valmarska A.</ce:indexed-name><ce:surname>Valmarska</ce:surname></author><author seq="2"><ce:initials>D.</ce:initials><ce:indexed-name>Miljkovic D.</ce:indexed-name><ce:surname>Miljkovic</ce:surname></author><author seq="3"><ce:initials>S.</ce:initials><ce:indexed-name>Konitsiotis S.</ce:indexed-name><ce:surname>Konitsiotis</ce:surname></author><author seq="4"><ce:initials>D.</ce:initials><ce:indexed-name>Gatsios D.</ce:indexed-name><ce:surname>Gatsios</ce:surname></author><author seq="5"><ce:initials>N.</ce:initials><ce:indexed-name>Lavrac N.</ce:indexed-name><ce:surname>Lavrač</ce:surname></author><author seq="6"><ce:initials>M.</ce:initials><ce:indexed-name>Robnik Ikonja M.</ce:indexed-name><ce:surname>Robnik Ikonja</ce:surname></author></ref-authors><ref-sourcetitle>Artif. Intell. Med.</ref-sourcetitle><ref-publicationyear first="2018"/><ref-volisspag><voliss volume="91"/><pagerange first="82" last="95"/></ref-volisspag></ref-info><ref-fulltext>Valmarska, A., Miljkovic, D., Konitsiotis, S., Gatsios, D., Lavrač, N., Robnik-ikonja, M.: Symptoms and medications change patterns for Parkinson’s disease patients stratification. Artif. Intell. Med. 91, 82–95 (2018)</ref-fulltext><ce:source-text>Valmarska, A., Miljkovic, D., Konitsiotis, S., Gatsios, D., Lavrač, N., Robnik-ikonja, M.: Symptoms and medications change patterns for Parkinson’s disease patients stratification. Artif. Intell. Med. 91, 82–95 (2018)</ce:source-text></reference></bibliography></tail></bibrecord></item></abstracts-retrieval-response>